medigraphic.com
A partir del año 2010, la Revista Oficial del INER cambió a NCT (Neumología y Cirugía de Tórax)

 Ver actualización

2005, Number 3

<< Back Next >>

Rev Inst Nal Enf Resp Mex 2005; 18 (3)

Platelet function beyond haemostasis: Role in respiratory diseases

Guzmán GAM, Maldonado NL, Mendoza AR, Hicks GJJ

Language: Spanish
References: 40
Page: 240-246
PDF size: 66.97 Kb.


ABSTRACT

Platelets store different chemical mediators and synthetize various types of proteins from preformed RNA; they also interact with different particles, components of the extracellular matrix and with different kinds of cells. This characteristics enable platelets to have important roles in hemostasis, thrombosis, inflammation, tissue remodeling and possibly in mechanisms of innate defense.


REFERENCES

  1. Weyrich AS, Lindemann S, Zimmerman GA. The evolving role of platelets in inflammation. J Thromb Haemost 2003;1:1897-1905.

  2. Weyrich AS, Zimmerman GA. Platelets: signaling cells in the immune continuum. Trends Immunol 2004;25:489-495.

  3. Lewis JC, Maldonado JE, Mann KG. Phagocytosis in human platelets: localization of acid phosphatase-positive phagosomes following latex uptake. Blood 1976;47:833-840.

  4. Zucker-Franklin. Endocytosis by human platelets: metabolic and freeze-fracture studies. J Cell Biol 1981;91:706-715.

  5. Clawson CC, Rao GHR, White JG. Platelet interaction with bacteria. IV. Stimulation of the release reaction. Am J Pathol 1975;81:411-420.

  6. Joseph M, Auriault C, Capron A, Vorng H, Viens P. A new function of platelets: IgE-dependent killing of schistosomes. Nature 1984;302:810-812.

  7. Mesenguer J, Esteban MA, Rodríguez A. Are thrombocytes and platelets true phagocytes? Microsc Res Tech 2002;57:491-497.

  8. Gear AR, Camerini D. Platelet chemokines and chemokine receptors: linking hemostasis, inflammation, and host defense. Microcirculation 2003;10:335-350.

  9. Booyse FM, Rafelson ME. Stable messenger RNA in the synthesis of contractile proteins in human platelets. Biochim Biophys Acta 1967;145:188-190.

  10. Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, Bahou WF. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 2003;101:2285-2293.

  11. Kieffer N, Guichard J, Farcet JP, Vainchenker W, Breton-Gorius J. Biosynthesis of major platelets proteins in human blood platelets. Eur J Biochem 1987; 164:189-195.

  12. Lindemann S, Tolley ND, Dixon DA, et al. Activated platelets mediate inflammatory signaling by regulated interleukin 1beta synthesis. J Cell Biol 2001; 154:485-490.

  13. Rosenwald IB, Pechet L, Han A, et al. Expression and translation initiation factors e1F-4E and e1F-2alpha and a potential physiologic role of continuous protein synthesis in human platelets. Thromb Haemost 2001; 85:142-151.

  14. Brown EJ, Schreiber SL. A signaling pathway to translational control. Cell 1996; 86: 517-520.

  15. Lindemann S, Tolley ND, Eyre JR, Kraiss LW, Mahoney TM, Weyrich AS. Integrins regulates the intracellular distribution of eukaryotic initiation factor 4E in platelets: a checkpoint for translational control. J Biol Chem 2001;276:33947-33951.

  16. Paul A, Wilson S, Belham CM, et al. Stress-activated protein kinases: activation, regulation and function. Cell Signal 1997;9:403-410.

  17. Kramer RM, Roberts EF, Strifler BA, Johnstone EM. Thrombin induces activation of p38 MAP kinase in human platelets. J Biol Chem 1995;270:27395-27398.

  18. Brown SB, Clarke MC, Magowan L, Sanderson H, Savill J. Constitutive death of platelets leading to scavenger receptor-mediated phagocytosis: a caspase-independent cell clearance program. J Biol Chem 2000;275:5987-5996.

  19. Czapiga M, Gao JL, Kirk A, Lekstrom-Himes J. Human platelets exhibit chemotaxis using functional N-formyl peptide receptors. Exp Hematol 2005;33:73-84.

  20. Martin JF, Slater DN, Trowbridge EA. Abnormal intrapulmonary platelet production: a possible cause of vascular and lung disease. Lancet 1983;1:793-796.

  21. Beasley R, Roche WR, Roberts JA, Holgate ST. Cellular events in the bronchi in mild asthma and after bronchial provocation. Am Rev Respir Dis 1989; 139:806-817.

  22. Metzger WJ, Sjoerdsma K, Richerson HB, et al. Platelets in bronchoalveolar lavage from asthmatic patients and allergic rabbits with allergen-induced late phase responses. Agents Actions Suppl 1987; 21:151-159.

  23. Gresele P, Dottorini M, Selli ML, et al. Altered platelet function associated with the bronchial hyper-responsiveness accompanying nocturnal asthma. J Allergy Clin Immunol 1993;91:894-902.

  24. Coyle AJ, Page CP, Atkinson L, Flanagan R, Metzger WJ. The requirement for platelets in allergen-induced late asthmatic airway obstruction. Eosinophil infiltration and heightened airway responsiveness in allergic rabbits. Am Rev Respir Dis 1990;142:587-593.

  25. Pitchford SC, Yano H, Lever R, et al. Platelets are essential for leukocyte recruitment in allergic inflammation. J Allergy Clin Immunol 2003;112:109-118.

  26. Ulfman LH, Joosten DP, van Aalst CW, et al. Platelets promote eosinophil adhesion of patients with asthma to endothelium under flow conditions. Am J Respir Cell Mol Biol 2003;28:512-519.

  27. Morley J, Sanjar S, Page CP. The platelet in asthma. Lancet 1984;1:1142-1144.

  28. Clark RA, Folkvord JM, Hart CE, Murray MJ, McPherson JM. Platelet isoforms of platelet-derived growth factor stimulate fibroblasts to contract collagen matrices. J Clin Invest 1989;84:1036-1040.

  29. Zhu Y, Skold CM, Liu X, et al. Fibroblast and monocyte macrophages contract and degrade three-dimensional collagen gels in extended co-culture. Respir Res 2001;2:295-299.

  30. Zagai U, Fredriksson K, Rennard SI, Lundahl J, Skold M. Platelets stimulate fibroblast-mediated contraction of collagen gels. Respir Res 2003;4:13.

  31. Pitchford SC, Riffo-Vasquez Y, Sousa A, et al. Platelets are necessary for airwall remodeling in a murine model of chronic allergic inflammation. Blood 2004; 103:639-647.

  32. Wedzicha JA, Syndercombe-Court D, Tan KC. Increased platelet aggregate formation in patients with chronic airflow obstruction and hypoxemia. Thorax 1991; 46:504-507.

  33. Ferroni P, Basili S, Pulcinelli FM, et al. In vivo thrombin generation and platelet hyperactivity in patients with chronic obstructive pulmonary disease. Platelets 1994;5:276-277.

  34. Basili S, Ferroni P, Pulcinelli FM, et al. Potential usefulness of antiplatelet agents in patients with chronic obstructive pulmonary disease. Thromb Res 1996; 4:279-284.

  35. Davi G, Basili S, Vieri M, et al. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. Am J Crit Care Med 1997;156:1794-1799.

  36. Ferroni P, Basili S, Martini F, et al. Soluble P-selectin as a marker of platelet hyperactivity in patients with chronic obstructive pulmonary disease. J Investing Med 2000;48:21-27.

  37. Radomski MW, Palmer RM, Moncada S. An L-arginine/nitric oxide pathway present in human platelet regulates aggregation. Proc Natl Acad Sci USA 1990;87:5193-5197.

  38. Freedman JE, Loscalzo J, Barnard MR, Alpert C, Keaney JF, Michelson AD. Nitric oxide released from activated platelets inhibits platelet recruitment. J Clin Invest 1997;100:350-356.

  39. Ichiki K, Ikeda H, Haramaki N, Ueno T, Imaizumi T. Long-term smoking impairs platelet-derived nitric oxide release. Circulation 1996;94:3109-3114.

  40. Takajo Y, Ikeda H, Haramaki N, Murohara T, Imaizumi T. Augmented oxidative stress of platelets in chronic smokers. Mechanisms of impaired platelet-derived nitric oxide bioactivity and augmented platelet agreegability. J Am Coll Cardiol 2001;38:1320-1327.




2020     |     www.medigraphic.com